230 related articles for article (PubMed ID: 35954378)
1. Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma.
Liu X; Ning J; Liu X; Chan WCJ
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954378
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas.
Boddicker RL; Razidlo GL; Feldman AL
Small GTPases; 2019 Jan; 10(1):33-39. PubMed ID: 27898263
[TBL] [Abstract][Full Text] [Related]
3. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Heavican TB; Bouska A; Yu J; Lone W; Amador C; Gong Q; Zhang W; Li Y; Dave BJ; Nairismägi ML; Greiner TC; Vose J; Weisenburger DD; Lachel C; Wang C; Fu K; Stevens JM; Lim ST; Ong CK; Gascoyne RD; Missiaglia E; Lemonnier F; Haioun C; Hartmann S; Pedersen MB; Laginestra MA; Wilcox RA; Teh BT; Yoshida N; Ohshima K; Seto M; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; d'Amore F; Inghirami G; Bertoni F; de Leval L; Gaulard P; Staudt LM; McKeithan TW; Pileri S; Chan WC; Iqbal J
Blood; 2019 Apr; 133(15):1664-1676. PubMed ID: 30782609
[TBL] [Abstract][Full Text] [Related]
4. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
[TBL] [Abstract][Full Text] [Related]
5. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.
Boddicker RL; Razidlo GL; Dasari S; Zeng Y; Hu G; Knudson RA; Greipp PT; Davila JI; Johnson SH; Porcher JC; Smadbeck JB; Eckloff BW; Billadeau DD; Kurtin PJ; McNiven MA; Link BK; Ansell SM; Cerhan JR; Asmann YW; Vasmatzis G; Feldman AL
Blood; 2016 Sep; 128(9):1234-45. PubMed ID: 27297792
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma.
Cortes JR; Filip I; Albero R; Patiño-Galindo JA; Quinn SA; Lin WW; Laurent AP; Shih BB; Brown JA; Cooke AJ; Mackey A; Einson J; Zairis S; Rivas-Delgado A; Laginestra MA; Pileri S; Campo E; Bhagat G; Ferrando AA; Rabadan R; Palomero T
Cell Rep; 2022 Apr; 39(3):110695. PubMed ID: 35443168
[TBL] [Abstract][Full Text] [Related]
7. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
Timmins MA; Wagner SD; Ahearne MJ
Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
[TBL] [Abstract][Full Text] [Related]
8. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.
Nicolae A; Bouilly J; Lara D; Fataccioli V; Lemonnier F; Drieux F; Parrens M; Robe C; Poullot E; Bisig B; Bossard C; Letourneau A; Missiaglia E; Bonnet C; Szablewski V; Traverse-Glehen A; Delfau-Larue MH; de Leval L; Gaulard P
Mod Pathol; 2022 Aug; 35(8):1126-1136. PubMed ID: 35301414
[TBL] [Abstract][Full Text] [Related]
9. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
10. [Genetic alterations in new category of Peripheral T-cell lymphoma, not otherwise specified].
Fukumoto K
Rinsho Ketsueki; 2022; 63(12):1657-1667. PubMed ID: 36653140
[TBL] [Abstract][Full Text] [Related]
11. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas.
Abate F; da Silva-Almeida AC; Zairis S; Robles-Valero J; Couronne L; Khiabanian H; Quinn SA; Kim MY; Laginestra MA; Kim C; Fiore D; Bhagat G; Piris MA; Campo E; Lossos IS; Bernard OA; Inghirami G; Pileri S; Bustelo XR; Rabadan R; Ferrando AA; Palomero T
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):764-769. PubMed ID: 28062691
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG).
Ohki K; Kiyokawa N; Watanabe S; Iwafuchi H; Nakazawa A; Ishiwata K; Ogata-Kawata H; Nakabayashi K; Okamura K; Tanaka F; Fukano R; Hata K; Mori T; Moriya Saito A; Hayashi Y; Taga T; Sekimizu M; Kobayashi R;
Br J Haematol; 2021 Aug; 194(4):718-729. PubMed ID: 34258755
[TBL] [Abstract][Full Text] [Related]
13. Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay.
Drieux F; Ruminy P; Sater V; Marchand V; Fataccioli V; Lanic MD; Viennot M; Viailly PJ; Sako N; Robe C; Dupuy A; Vallois D; Veresezan L; Poullot E; Picquenot JM; Bossard C; Parrens M; Lemonnier F; Jardin F; de Leval L; Gaulard P
J Mol Diagn; 2021 Aug; 23(8):929-940. PubMed ID: 34147695
[TBL] [Abstract][Full Text] [Related]
14. Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine.
Zhang Y; Lee D; Brimer T; Hussaini M; Sokol L
Front Oncol; 2020; 10():898. PubMed ID: 32637355
[TBL] [Abstract][Full Text] [Related]
15. Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene.
Liang PI; Chang ST; Lin MY; Hsieh YC; Chu PY; Chen CJ; Lin KJ; Jung YC; Hwang WS; Huang WT; Chang WC; Ye H; Chuang SS
Int J Clin Exp Pathol; 2014; 7(9):6097-107. PubMed ID: 25337257
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive genomic analysis identifying heterogeneity in peripheral T-cell lymphoma.
Yoshida N; Yamada K; Ohshima K
Cancer Sci; 2021 Apr; 112(4):1339-1347. PubMed ID: 33576080
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.
de Pádua Covas Lage LA; Brito CV; Levy D; Culler HF; Freitas Couto SC; de Oliveira LBA; Nogueira Zerbini MC; Rocha V; Pereira J
Leuk Res; 2022 Mar; 114():106794. PubMed ID: 35131666
[TBL] [Abstract][Full Text] [Related]
19. Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas.
Rodríguez-Pinilla SM; Sánchez ME; Rodríguez J; García JF; Sánchez-Espiridión B; Lamana LF; Sosa G; Rivero JC; Menárguez J; Gómez IB; Camacho FI; Guillen PR; Orduña CP; Rodríguez G; Barrionuevo C; Franco R; Mollejo M; Marco JF; de Otazu RD; Piris MA
Blood Cancer J; 2013 Apr; 3(4):e111. PubMed ID: 23599023
[TBL] [Abstract][Full Text] [Related]
20. Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.
Agostinelli C; Rizvi H; Paterson J; Shende V; Akarca AU; Agostini E; Fuligni F; Righi S; Spagnolo S; Piccaluga PP; Clark EA; Pileri SA; Marafioti T
Am J Surg Pathol; 2014 Oct; 38(10):1349-59. PubMed ID: 25118816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]